Özge Atılgan Karakulak

Practice Areas

Life Sciences

Intellectual Property

Patents and Utility Models

Competition

Professional Memberships

International Bar Association (IBA), Intellectual Property and Entertainment Law Committee Advisory Board Member

Seton Hall University School of Law Healthcare Compliance Certification Program, Advisory Board Member

Association Internationale pour la Protection de la Propriété Intellectuelle (AIPPI)

Licensing Executives Society (LES)

Galatasaray University Alumni Association

Transparency International Turkey, Board of Directors Member

Career

Özge Atılgan Karakulak has been with the firm since 2005 and has been a partner since 2013. She is chair of the firm’s life sciences industry and competition practices and co-chair of patent and utility models practice.

With the combination of Özge’s advisory and litigation expertise and in-depth knowledge of the life sciences sector, she advises clients across all phases of the business cycle of life science products, such as registration / authorization procedures, promotion practices, pricing and reimbursement regulations, distribution relationships and co-marketing deals, as well as on issues of merger control, vertical restraints and abusive conduct.

Özge has acted on behalf of originators in numerous complex patent infringement and validity actions in the pharmaceutical industry and she was involved in the first ever pharmaceutical data exclusivity and unfair competition actions in Türkiye.

In addition her corporate work, Özge advises multinational industry associations in Türkiye on numerous regulatory policy papers and drafting regulations for the Turkish government authorities.

Languages Spoken

English

Turkish

Publications

The Euro Value Applied to Pharmaceutical Prices Has Been Increased by 16.9%

Gün + Partners, Co-Author, Dec 23, 2025

An Important European Precedent: Legal Consequences of Statements Concerning Competitors and Its Implications for Türkiye

Gün + Partners, Co-Author, Jul 24, 2025

Medicines and Medical Devices Sectors: Current Status and Evolving Dynamics

Gün + Partners, Co-Author, Feb 25, 2025

Market Availability of Products and Parallel Trade

Gün + Partners, Co-Author, Feb 25, 2025

Named Patient Program

Gün + Partners, Co-Author, Feb 25, 2025

Developments in the Field of Medical Devices

Gün + Partners, Co-Author, Feb 25, 2025

Use of Hemp in Production of Pharmaceuticals

Gün + Partners, Co-Author, Feb 25, 2025

Food Supplements

Gün + Partners, Co-Author, Feb 25, 2025

Interactions with Health Care Professionals, Transfer of Values and Conditions of Payment

Gün + Partners, Co-Author, Feb 25, 2025

Market Access - Alternative Reimbursement Models

Gün + Partners, Co-Author, Feb 25, 2025

Fixed Exchange Rate in Pricing of Pharmaceuticals and its Impact

Gün + Partners, Co-Author, Feb 25, 2025

Pharmaceuticals, Medical Devices, Digitalization: What Awaits the Healthcare Sectors in the 12th Development Plan and the 2025 Presidential Annual Program?

Legalink Newsletter, Co-Author, Dec 24, 2024

Evaluating Disparaging Practices against Competitors in the Pharmaceutical Sector: A Competition Law Perspective

Gün + Partners, Co-Author, Dec 17, 2024

IP in Business Transactions 2024 in Turkey

Practical Law, Co-Author, Sep 13, 2024

Named Patient Program

Gün + Partners, Co-Author, Aug 14, 2024